GSK CEO addresses declining trust in vaccines following Trump re-election
GSK CEO Emma Walmsley said the sector would need to wait to see who is appointed in key roles in the Trump administration to ...
pharmaphorum4d
GSK goes all-in on CureVac’s mRNA vaccines
GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID ...
Zacks.com on MSN6d
Should Moderna Stock Be in Your Portfolio Pre-Q3 Earnings?
When MRNA reports third-quarter earnings, investors will likely focus on the sales performance of its recently approved RSV ...
pharmaphorum3d
Vir awarded $1 billion multi-year BARDA influenza contract
in addition to influenza A and COVID-19, the latter of which Vir (together with GSK) previously delivered the antibody sotrovimab (Xevudy) for. The company also co-discovered ansuvimab-zykl for ...
(CIIE) Global medical giants tapping Chinese market at import expo
With an array of new medicines and medical devices on display global medical companies are looking to tap further into the ...
Vaccine makers exposed to political pathogen
It would be unhealthy to let Robert F. Kennedy Jr. take charge of U.S. physical well-being. President-elect Donald Trump said on the campaign trail that he wants the anti-vaccine activist to “run wild ...
China Internet Information Center3d
Global medical giants tapping Chinese market at import expo
With an array of new medicines and medical devices on display, global medical companies are looking to tap further into the ...
China Internet Information Center4d
(CIIE) Economic Watch: Global medical giants tapping Chinese market at import expo
"China market is one of the most attractive markets for Edwards," said Leo Tam, senior director of the business unit of Transcatheter Aortic Valve Replacement, Edwards Lifesciences China, citing a lot ...
Medscape1d
Immunogenicity and Safety of Inactivated Quadrivalent and Trivalent Influenza Vaccines in Children 18–47 Months of Age
and inactivated trivalent influenza vaccine (TIV; Fluarixâ„¢, GlaxoSmithKline Vaccines) in primed and unprimed cohorts of children aged from 18 to 47 months. The main aim of the study was to ...
India Infoline5d
Glaxosmithkline Pharmaceuticals Ltd Company Summary
GlaxoSmithKline Pharmaceuticals Limited is ... Invasive Disease caused by H, Influenza, Chickenpox, Diphtheria, Pertussis, Tetanus, Rotavirus, Cervical Cancer and Others. They have two ...
Medscape6d
New Adjuvanted Vaccines in Pregnancy: What is Known About Their Safety?
Another pandemic influenza vaccine, Humenza® (Sanofi Pasteur ... as well as in a Hepatitis B vaccine (Fendrix® [GSK Biologicals]). For this adjuvant, no effect on any of the phases of ...
Reuters6d
Canada approves GSK's RSV vaccine for adults aged 50 to 59
Nov 5 (Reuters) - GSK (GSK.L), opens new tab has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said on Tuesday, making it the ...